Electrolytes and alcohol on GLP-1 medications Alcohol and GLP-1 medications have a complicated relationship
The American College of Cardiology/American Heart Association/The Obesity Society guidelines emphasize individualized treatment plans incorporating lifestyle modification, behavioral therapy, pharmacotherapy when appropriate, and metabolic/bariatric surgery for eligible patients
Ratziu V, Charlotte F, Bernhardt C et al (2010) Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
Diabetes Care 38(9):16871693
At 12 mg, the average increase was around 6.7 beats per minute, peaking around week 24 and declining toward baseline by weeks 36 to 48
Common pathophysiological mechanisms of metabolic syndrome and NDD include insulin resistance of the brain, neuroinflammation, oxidative stress, dysfunction of the BBB, mitochondrial damage, dysbiosis of the intestinal microbiota and changes in the renin-angiotensin system
